Autoimmune lymphoproliferative syndrome: Report of two cases and review of the literature

Annals of Hematology

Volumn 81, Issue 11, 2002, Pages 651-653

  Ören, Hale ^a   Özkal, Sermin ^a   Gülen, Hüseyin ^a   Duman, Murat ^a   Uçar, Canan ^a   Atabay, Berna ^a   Yilmaz, Şebnem ^a   Kargi, Aydanur ^a   Irken, Gülersu ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Autoimmune lymphoproliferative syndrome; Canale Smith syndrome; Double negative T cells

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PREDNISOLONE;

APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOIMMUNITY; CASE REPORT; CELL SURVIVAL; CHILDHOOD DISEASE; CLINICAL FEATURE; COOMBS TEST; EARLY DIAGNOSIS; FEMALE; GENE MUTATION; HELPER CELL; HEPATOMEGALY; HISTOPATHOLOGY; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INFANT; LYMPH NODE; LYMPHADENOPATHY; LYMPHOCYTE; LYMPHOPROLIFERATIVE DISEASE; MEDICAL LITERATURE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SPLEEN; SPLENOMEGALY; SUPPRESSOR CELL;

AUTOIMMUNE DISEASES; FEMALE; HEPATOMEGALY; HUMANS; IMMUNOPHENOTYPING; INFANT; LYMPH NODES; LYMPHOPROLIFERATIVE DISORDERS; SPLENOMEGALY; T-LYMPHOCYTE SUBSETS;

EID: 0036942560     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-002-0537-5     Document Type: Article

References (22)

1. Canale VC, Smith CH (1967) Chronic lymphadenopathy simulating malignant lymphoma. J Pediatr 70:891-899
2. Kellerer K, Mutz I (1976) Chronische pseudomaligne immunoproliferation (Canale-Smith syndrome). Eur J Pediatr 121:203-213
3. Malzberg MS, Haller JO, Snieckus PJ, Halpern SL (1991) Canale-Smith syndrome: chronic pseudomalignant lymphadenopathy. J Clin Ultrasound 19:172-174
4. Sneller MC, Wang J, Dale JK, Strober W, Middelton LA, Choi Y, Fleisher TA, Lim MS, Jaffe ES, Puck JM, Leonardo MJ, Straus SE (1997) Clinical, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Blood 89:1341-1348
5. Infante AJ, Britton HA, DeNapoli T, Middelton LA, Leonardo MJ, Jackson CE, Wang J, Fleisher T, Straus SE, Puck J (1998) The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosis. J Pediatr 133:629-633
6. Drappa J, Vaishnaw AK, Sullivan KE, Chu JL, Elkon KB (1996) Fas gene mutation in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity. N Engl J Med 335:1643-1649
7. Vaishnaw AK, Taubi E, Ohsako S, Drappa J, Buys S, Estrada J, Sitarz A, Zemel L, Chu JL, Elkon KB (1999) The spectrum of apoptotic defects and clinical manifestations, including systemic lupus erythematosus, in humans with CD45 (Fas/Apo-1) mutations. Arthritis Rheum 42:1833-1842
8. Jackson CE, Puck JM (1999) Autoimmune lymphoproliferative syndrome, a disorder of apoptosis. Curr Opin Pediatr 11:521-527
9. Famularo G, Nucera. E, Marcellini S, De Simone C (1999) Fas/Fas ligand on the road: an apoptotic pathway common to AIDS, autoimmunity, lymphoproliferation and transplantation. Med Hypotheses 53:50-62
10. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S (1992) Lymphoproliferation disorder in mice explained by defect in Fas antigen that mediates apoptosis. Nature 356:314
11. Takahashi T, Taraka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, Nagata S (1994) Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969
12. Fisher G, Rosenberg F, Straus S, Dale J, Middelton L, Lin A, Strober W, Lenardo M, Puck J (1995) Dominant interfering fas gene mutation impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935-946
13. Straus SE, Sneller M, Leonardo MJ, Puck JM, Strober W (1999) An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome. Ann Intern Med 130:591-601
14. Lim MS, Straus SE, Dale JK, Fleisher TA, Stetler-Stevenson M, Strober W, Sneller MC, Puck JM, Leonardo MJ, Elenitoba-Johnson KSJ, Lin AY, Raffeld M, Jaffe ES (1998) Pathological findings in human autoimmune lymphoproliferative syndrome. Am J Pathol 153:1541-1550
15. Segel GB (2000) Hemolytic anemias resulting from extracellular factors. In: Behrman RE, Kliegman RM, Jenson HB (eds) Nelson textbook of pediatrics, 16th edn. WB Saunders, Philadelphia, pp 1491-1493
16. Le Deist F, Gmile JF, Rieux-Laucat F, Benkerrou M, Roberts I, Brousse N, Fischer A (1996) Clinical, immunological and pathological consequences of Fas-deficient conditions. Lancet 348:719-723
17. Rieux-Laucat F, Blachere S, Danielan S, De Villartay JP, Oleastro M, Solary E, Bader-Meunier BB, Arkwright P, Pondare C, Bernaudin F, Chapel H, Nielsen S, Berrah M, Fischer A, Le Deist F (1999) Lymphoproliferative syndrome with autoimmunity: a possible genetic basis for dominant, expression of the clinical manifestations. Blood 94:2575-2582
18. Dianzani U, Bragardo M, DiFranco D, Alliaudi C, Scagni P, Buonfiglio D, Redoglia V, Bonissoni S, Correra A, Dianzani I, Ramenghi U (1997) Deficiency of the Fas apoptosis pathway without Fas gene mutations in pediatric patients with autoimmunity/lymphoproliferation. Blood 89:2871-2879
19. Bettinardi A, Brugnoni D, Quirosroldan E, Malagoli A, Lagrutta S, Correra A, Notarangelo LD (1997) Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome - a molecular and immunological analysis. Blood 89:902-909
20. Van Der Werff Ten Bosch JE, Demaret C, Balduck N, Bakkus MHC, De Raeve H, Desprechins B, Otten J, Thielemans K (1998) The use of the anti-malaria drug Fansidar (pyrimethamine and sulfadoxine) in the treatment of a patient with autoimmune lymphoproliferative syndrome and Fas deficiency. Br J Haematol 102:578-581
21. Ceretelli S, Petrini M, Galimberti S, Frizzera G (2001) Interferon-α activity in a case of severe autoimmune lymphoproliferative disease. Am Hematol 80:49-52
22. Sleight BJ, Prasad VS, De Laat C, Steele P, Ballard E, Arceci RJ, Sidman CL (1998) Correction of autoimmune lymphoproliferative syndrome by bone marrow transplantation. Bone Marrow Transplant 22:375-380